Depression and anxiety in COPD
Depression and anxiety in COPD are regular in patients with chronic obstructive pulmonary disease (COPD), assessments of their pervasiveness differ significantly. These likely reflect the assortment of scales and strategies used to measure such symptoms. Patients with COPD with three or more comorbidities are more likely to be frequently hospitalized and may die prematurely compared to COPD patients without comorbidities. An uplifted experience of dyspnoea is probably contributing component to anxiety. Feelings of depression may be precipitated by the loss and grief associated with the disability of COPD. Smoking has been associated with nicotine addiction, and the factors that contribute to smoking may also predispose to anxiety and depressive disorders. The cause of depression and anxiety symptoms are multifactorial and include behavioural, social and biological factors. Lung Conferences exhibits randomized controlled trials show that activity exercise training and precisely chose pharmacological treatment are regularly effective in ameliorating anxiety and depression.
- Prevalence in COPD
- Classification and diagnostic criteria
- Clinical features and impact
- Screening and diagnosis
- Risk factors
- Mechanism of potential association with COPD
Related Conference of Depression and anxiety in COPD
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Depression and anxiety in COPD Conference Speakers
Recommended Sessions
- COPD Pathogenesis
- Drug Discovery of COPD
- Asthma and COPD
- Chronic Obstructive Pulmonary Disease
- Co-Morbidities of COPD
- COPD and Cardiovascular Diseases
- COPD Complications
- COPD Exacerbations
- COPD Therapeutics
- COPD: Sign and Symptoms
- Depression and anxiety in COPD
- Epidemiology of COPD
- Genetic risk factor of COPD
- Lung cancer
- Pathophysiology of COPD
- Pediatric Pulmonary, Critical care and Sleep
- Pulmonary diseases treatment and therapies
- Pulmonary Hypertension
- Self-Management and Prevention of COPD
- Types of COPD
Related Journals
Are you interested in
- Allergy testing and treatment in respiratory diseases - Euro Pulmonology 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Bronchial thermoplasty for asthma management - Euro Pulmonology 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic cough evaluation and treatment strategies - Euro Pulmonology 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and its impact on respiratory health - Euro Pulmonology 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Genetics of respiratory diseases and precision medicine - Euro Pulmonology 2024 (France)
- Imaging techniques in pulmonary medicine - Euro Pulmonology 2024 (France)
- Interstitial lung disease and lung transplant outcomes - Euro Pulmonology 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung cancer and personalized medicine approaches - Euro Pulmonology 2024 (France)
- Lung cancer screening and early detection programs - Euro Pulmonology 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung microbiome and respiratory diseases - Euro Pulmonology 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Non-invasive ventilation techniques and outcomes - Euro Pulmonology 2024 (France)
- Occupational asthma and work-related respiratory diseases - Euro Pulmonology 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pulmonary arterial hypertension diagnosis and management - Euro Pulmonology 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary drug delivery systems and innovations - Euro Pulmonology 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary edema pathophysiology and treatment - Euro Pulmonology 2024 (France)
- Pulmonary embolism diagnosis and management - Euro Pulmonology 2024 (France)
- Pulmonary rehabilitation in critically ill patients - Euro Pulmonology 2024 (France)
- Pulmonary sarcoidosis diagnosis and treatmen - Euro Pulmonology 2024 (France)
- Respiratory failure management in ICU patients - Euro Pulmonology 2024 (France)
- Respiratory syncytial virus updates and management - Euro Pulmonology 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)